Geffers C, Gastmeier P, Daschner F, Rüden H
Institut für Hygieneder Freien Universität Berlin.
Zentralbl Chir. 2001 Feb;126(2):84-92. doi: 10.1055/s-2001-12415.
Among all hospitalized patients, surgical site infections (SSI) are the third most frequently hospital-acquired-infection. SSIs remain a substantial cause of morbidity and mortality among surgical patients. This may be partially explained by the emergence of antimicrobial-resistant pathogens and the increased numbers of patients who are elderly and/or have a wide variety of chronic, debilitating, or immunocompromising underlying diseases. This is why it is essential to implement SSI prevention measures. In April 1999 the Centers for Disease Control and Prevention (CDC) presented the "Guideline for Prevention of Surgical Site Infection". The recommendations represent the consensus of the Hospital Infection Control Practices Advisory Committee (HICPAC) regarding strategies for the prevention of SSIs. Whenever possible, the recommendations are based on data from well-designed scientific studies. This guideline is a major step forward and is also essential to optimize the management of surgical patients in Germany.
在所有住院患者中,手术部位感染(SSI)是第三常见的医院获得性感染。手术部位感染仍然是外科患者发病和死亡的重要原因。抗菌耐药病原体的出现以及老年患者和/或患有各种慢性、衰弱性或免疫功能低下基础疾病的患者数量增加,可能部分解释了这一现象。这就是实施手术部位感染预防措施至关重要的原因。1999年4月,疾病控制与预防中心(CDC)发布了《手术部位感染预防指南》。这些建议代表了医院感染控制实践咨询委员会(HICPAC)关于预防手术部位感染策略的共识。只要有可能,这些建议都基于精心设计的科学研究数据。本指南向前迈出了重要一步,对于优化德国外科患者的管理也至关重要。